Medical sales growth of 5.9% was driven by robust demand in robotic surgery, patient surfaces, and interventional segments, partially offset by temporary inventory destocking at two major wound care customers. Non-medical revenue declined 15% as the company executes a deliberate strategic exit from the automotive market to focus on high-growth MedTech segments. Earnings growth lagged revenue due to simultaneous start-up costs for four major program launches and persistent labor inefficiencies at the A ...